Chidubem Ogwulu

ORCID: 0000-0002-8133-7021
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Reproductive tract infections research
  • Adolescent Sexual and Reproductive Health
  • Ectopic Pregnancy Diagnosis and Management
  • Maternal and Perinatal Health Interventions
  • Reproductive Health and Contraception
  • Mechanical Circulatory Support Devices
  • Syphilis Diagnosis and Treatment
  • Sexual function and dysfunction studies
  • Cardiac Arrest and Resuscitation
  • Global Health Care Issues
  • Cardiac Structural Anomalies and Repair
  • HIV/AIDS Research and Interventions
  • Health Systems, Economic Evaluations, Quality of Life
  • Global Maternal and Child Health
  • Grief, Bereavement, and Mental Health
  • Healthcare Policy and Management
  • HIV, Drug Use, Sexual Risk
  • Endometriosis Research and Treatment
  • Intergenerational Family Dynamics and Caregiving
  • Pregnancy and Medication Impact
  • Maternal and fetal healthcare
  • Reproductive System and Pregnancy
  • Uterine Myomas and Treatments

University of Birmingham
2015-2025

Miscarriage Association
2019

BackgroundThe anti-progesterone drug mifepristone and the prostaglandin misoprostol can be used to treat missed miscarriage. However, it is unclear whether a combination of more effective than administering alone. We investigated treatment with plus would result in higher rate completion miscarriage compared alone.MethodsMifeMiso was multicentre, double-blind, placebo-controlled, randomised trial 28 UK hospitals. Women were eligible for enrolment if they aged 16 years older, diagnosed by...

10.1016/s0140-6736(20)31788-8 article EN cc-by-nc-nd The Lancet 2020-08-24

Background Progesterone is essential for a healthy pregnancy. Several small trials have suggested that progesterone therapy may rescue pregnancy in women with early bleeding, which symptom strongly associated miscarriage. Objectives (1) To assess the effects of vaginal micronised bleeding first 12 weeks (2) evaluate cost-effectiveness bleeding. Design A multicentre, double-blind, placebo-controlled, randomised trial Setting total 48 hospitals UK. Participants Women aged 16–39 years...

10.3310/hta24330 article EN publisher-specific-oa Health Technology Assessment 2020-06-01

Partner notification (PN) is a process aiming to identify, test and treat the sex partners of people (index patients) with sexually transmitted infections (STIs). Accelerated partner therapy (APT) PN method whereby healthcare professionals assess partners, by telephone consultation, before giving index patient antibiotics STI self-sampling kits deliver their partner(s). The Limiting Undetected Sexually Transmitted RedUce Morbidity programme aims determine effectiveness APT in heterosexual...

10.1136/bmjopen-2019-034806 article EN cc-by BMJ Open 2020-03-01

To assess the cost-effectiveness of mifepristone and misoprostol (MifeMiso) compared with only for medical management a missed miscarriage.Within-trial economic evaluation model-based analysis to set findings in context wider evidence range comparators. Incremental costs outcomes were calculated using nonparametric bootstrapping reported acceptability curves. Analyses performed from perspective UK's National Health Service (NHS).Twenty-eight UK NHS early pregnancy units.A cohort 711 women...

10.1111/1471-0528.16737 article EN BJOG An International Journal of Obstetrics & Gynaecology 2021-05-10

Trial design A randomised, parallel-group, double-blind, placebo-controlled multicentre study with health economic and nested qualitative studies to determine if mifepristone (Mifegyne ® , Exelgyn, Paris, France) plus misoprostol is superior alone for the resolution of missed miscarriage. Methods Women diagnosed miscarriage in first 14 weeks pregnancy were randomly assigned (1 : 1 ratio) receive 200 mg oral or matched placebo, followed by 800 μg 2 days later. web-based randomisation system...

10.3310/hta25680 article EN publisher-specific-oa Health Technology Assessment 2021-11-01

Background Sexually transmitted infections disproportionately affect young people and men who have sex with men. Chlamydia is Britain’s most common sexually infection. Partner notification a key intervention to reduce transmission of human immunodeficiency virus but hard implement. Accelerated partner therapy promising new approach. Objectives determine the effectiveness, costs acceptability accelerated for chlamydia in heterosexual model cost effectiveness impact on develop interventions...

10.3310/trqw3886 article EN publisher-specific-oa Programme Grants for Applied Research 2023-06-09

ABSTRACT Objective To investigate the cost-effectiveness of accelerated partner therapy (APT) compared with standard contact tracing for people sexually transmitted chlamydia infection in United Kingdom Design Economic evaluation using a model consisting two components: population-based transmission component, to estimate impact APT on prevalence, and an economic healthcare costs health outcomes. Setting Participants Hypothetical heterosexual population 50,000 men women aged 16-34 years....

10.1101/2021.07.27.21261128 preprint EN cc-by-nc-nd medRxiv (Cold Spring Harbor Laboratory) 2021-07-29

( N Engl J Med . 2019;380(19):1815–1824) This study aimed to determine whether the controversial use of progesterone therapy in women with early bleeding pregnancy could result a higher incidence live births than placebo. It was multicenter, randomized, double-blind, placebo-controlled trial evaluate progesterone, as compared placebo, vaginal pregnancy. Women received suppositories or from presentation 16 weeks if helps improve outcomes for

10.1097/01.aoa.0000603772.96889.98 article EN Obstetric Anesthesia Digest 2019-11-25

<h3>Background</h3> Accelerated partner therapy (APT) is a notification (PN) method whereby healthcare professionals assess sex partners by telephone, then send or give the index patient antibiotics and self-sampling kits for their partner(s). We determined effect of APT on proportions of: patients who test positive chlamydia at 12–24 weeks (primary outcome) treated (key secondary outcome). <h3>Methods</h3> did cross-over cluster-randomised controlled trial comparing APT, as an additional PN...

10.1136/sextrans-2021-sti.153 article EN 2021-07-01

ABSTRACT Background Eliciting health-state utility values (HSUVs) for some diseases is complicated by the mix of associated temporary (THSs) and chronic health states (CHSs). This study uses one such disease, chlamydia infection, to explore challenges. The objectives were to: Define a set descriptions related Derive HSUVs these (both chronic). Methods elicited seven (five THSs two CHSs) depicting symptoms chlamydia, developed using evidence from literature clinical experts. chained time...

10.1101/2021.06.15.21258547 preprint EN medRxiv (Cold Spring Harbor Laboratory) 2021-06-22

ABSTRACT Objectives Men who have sex with men (MSM) are disproportionately affected by sexually transmitted infections (STIs). Partner notification (PN) to identify, test and treat partners of MSM bacterial STIs is challenging because often report larger numbers a higher proportion one-off may be difficult engage. However, contribute onward transmission. Economic research on PN has typically focused heterosexual people evidence effectiveness in scant. We conducted systematic review economic...

10.1101/2021.06.08.21258534 preprint EN cc-by medRxiv (Cold Spring Harbor Laboratory) 2021-06-08

<h3>Background</h3> Accelerated partner therapy (APT) is a notification (PN) method whereby healthcare professionals assess sex partners by telephone, then send or give the index patient antibiotics and self-sampling kits for their partner(s). APT was implemented within cluster cross-over randomised control trial in 17 sexual health clinics Britain (2018–2019, ISRCTN Reference 15996256). We conducted an integral process evaluation to help explain experiences of using APT. <h3>Methods</h3>...

10.1136/sextrans-2021-sti.348 article EN Poster presentations 2021-07-01
Coming Soon ...